These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24816095)

  • 1. Sunitinib: from charge-density studies to interaction with proteins.
    Malińska M; Jarzembska KN; Goral AM; Kutner A; Woźniak K; Dominiak PM
    Acta Crystallogr D Biol Crystallogr; 2014 May; 70(Pt 5):1257-70. PubMed ID: 24816095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, in silico, in vitro, and in vivo investigation of 5-[¹¹C]methoxy-substituted sunitinib, a tyrosine kinase inhibitor of VEGFR-2.
    Caballero J; Muñoz C; Alzate-Morales JH; Cunha S; Gano L; Bergmann R; Steinbach J; Kniess T
    Eur J Med Chem; 2012 Dec; 58():272-80. PubMed ID: 23131541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The unbinding studies of vascular endothelial growth factor receptor-2 protein tyrosine kinase type II inhibitors.
    Kang CM; Liu DQ; Wang XY; Yu RL; Lv YT
    J Mol Graph Model; 2015 Jun; 59():130-5. PubMed ID: 25989626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structures of IL-2-inducible T cell kinase complexed with inhibitors: insights into rational drug design and activity regulation.
    Kutach AK; Villaseñor AG; Lam D; Belunis C; Janson C; Lok S; Hong LN; Liu CM; Deval J; Novak TJ; Barnett JW; Chu W; Shaw D; Kuglstatter A
    Chem Biol Drug Des; 2010 Aug; 76(2):154-63. PubMed ID: 20545945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermolecular interactions, charge-density distribution and the electrostatic properties of pyrazinamide anti-TB drug molecule: an experimental and theoretical charge-density study.
    Rajalakshmi G; Hathwar VR; Kumaradhas P
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2014 Jun; 70(Pt 3):568-79. PubMed ID: 24892603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seven 3-methylidene-1H-indol-2(3H)-ones related to the multiple-receptor tyrosine kinase inhibitor sunitinib.
    Spencer J; Chowdhry BZ; Hamid S; Mendham AP; Male L; Coles SJ; Hursthouse MB
    Acta Crystallogr C; 2010 Feb; 66(Pt 2):o71-8. PubMed ID: 20124685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in silico exploration of the interaction mechanism of pyrazolo[1,5-a]pyrimidine type CDK2 inhibitors.
    Li Y; Gao W; Li F; Wang J; Zhang J; Yang Y; Zhang S; Yang L
    Mol Biosyst; 2013 Sep; 9(9):2266-81. PubMed ID: 23864105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway.
    Yeramian A; Sorolla A; Velasco A; Santacana M; Dolcet X; Valls J; Abal L; Moreno S; Egido R; Casanova JM; Puig S; Vilella R; Llombart-Cussac A; Matias-Guiu X; Martí RM
    Int J Cancer; 2012 Feb; 130(4):967-78. PubMed ID: 21445974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profile and molecular modeling of 3-(indole-3-yl)-4-(3,4,5-trimethoxyphenyl)-1 H-pyrrole-2,5-dione (1) as a highly selective VEGF-R2/3 inhibitor.
    Peifer C; Krasowski A; Hämmerle N; Kohlbacher O; Dannhardt G; Totzke F; Schächtele C; Laufer S
    J Med Chem; 2006 Dec; 49(25):7549-53. PubMed ID: 17149885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charge density view on bicalutamide molecular interactions in the monoclinic polymorph and androgen receptor binding pocket.
    Korlyukov AA; Malinska M; Vologzhanina AV; Goizman MS; Trzybinski D; Wozniak K
    IUCrJ; 2020 Jan; 7(Pt 1):71-82. PubMed ID: 31949906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing an ensemble docking-based virtual screening strategy for kinase targets by considering protein flexibility.
    Tian S; Sun H; Pan P; Li D; Zhen X; Li Y; Hou T
    J Chem Inf Model; 2014 Oct; 54(10):2664-79. PubMed ID: 25233367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong and weak hydrogen bonds in protein-ligand complexes of kinases: a comparative study.
    Panigrahi SK
    Amino Acids; 2008 May; 34(4):617-33. PubMed ID: 18180869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electron density of two bioactive oligocyclic indole and oxindole derivatives obtained from low-order X-ray data and invariom application.
    Weber M; Grabowsky S; Hazra A; Naskar S; Banerjee S; Mondal NB; Luger P
    Chem Asian J; 2011 Jun; 6(6):1390-7. PubMed ID: 21433298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Charge density and electrostatic interactions of fidarestat, an inhibitor of human aldose reductase.
    Fournier B; Bendeif el-E; Guillot B; Podjarny A; Lecomte C; Jelsch C
    J Am Chem Soc; 2009 Aug; 131(31):10929-41. PubMed ID: 19594152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring binding mechanisms of VEGFR2 with three drugs lenvatinib, sorafenib, and sunitinib by molecular dynamics simulation and free energy calculation.
    Wang Y; Peng C; Wang G; Xu Z; Luo Y; Wang J; Zhu W
    Chem Biol Drug Des; 2019 May; 93(5):934-948. PubMed ID: 30689282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of novel 3-aryl-4-(1H-indole-3yl)-1,5-dihydro-2H-pyrrole-2-ones as vascular endothelial growth factor receptor (VEGF-R) inhibitors.
    Peifer C; Selig R; Kinkel K; Ott D; Totzke F; Schächtele C; Heidenreich R; Röcken M; Schollmeyer D; Laufer S
    J Med Chem; 2008 Jul; 51(13):3814-24. PubMed ID: 18529047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for the high-affinity binding of pyrrolotriazine inhibitors of p38 MAP kinase.
    Sack JS; Kish KF; Pokross M; Xie D; Duke GJ; Tredup JA; Kiefer SE; Newitt JA
    Acta Crystallogr D Biol Crystallogr; 2008 Jul; D64(Pt 7):705-10. PubMed ID: 18566506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced-fit docking studies of the active and inactive states of protein tyrosine kinases.
    Zhong H; Tran LM; Stang JL
    J Mol Graph Model; 2009 Nov; 28(4):336-46. PubMed ID: 19767223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantum-chemical insight into structure-reactivity relationship in 4,5,6,7-tetrahalogeno-1H-benzimidazoles: a combined X-ray, DSC, DFT/QTAIM, Hirshfeld surface-based, and molecular docking approach.
    Latosińska JN; Latosińska M; Maurin JK; Orzeszko A; Kazimierczuk Z
    J Phys Chem A; 2014 Mar; 118(11):2089-106. PubMed ID: 24597713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.